Form 4: Delek US Director Sells Shares Under 10b5-1 Plan

Delek US Holdings Director Shlomo Zohar sold 29,372 shares of common stock across multiple transactions in early March 2026, pursuant to a pre-arranged 10b5-1 trading plan.

Summary

• Director Shlomo Zohar of Delek US Holdings, Inc. sold a total of 29,372 shares of common stock.
• The sales occurred on March 4, 2026, and March 5, 2026.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on November 13, 2025.
• The shares were sold at prices ranging from $43.00 to $45.50 per share.
• Following these transactions, Mr. Zohar beneficially owns 18,989 shares of Delek US Holdings common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be perceived negatively, the execution under a pre-planned 10b5-1 plan mitigates concerns about immediate insider sentiment regarding the company's prospects.

Positives

• The transactions were conducted under a pre-arranged 10b5-1 plan, indicating a planned sale rather than a reaction to recent company news.

Negatives

• A director selling a significant number of shares could be perceived negatively by some investors, even if pre-planned.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 plan, are common for executives and directors managing their personal portfolios and do not necessarily reflect a negative outlook on the company's future performance or the broader energy refining industry.

Related Party Transactions

• Director Shlomo Zohar, a related party, sold common stock of Delek US Holdings, Inc.

Stakeholder Impact

• Shareholders may observe a slight increase in selling pressure due to the director's share sales, though the impact is likely minimal given the pre-planned nature of the transactions.

Key Dates

Recommendation

The insider sale by Director Shlomo Zohar was conducted under a pre-arranged 10b5-1 plan, which typically indicates a planned portfolio management decision rather than a reaction to new material information. While a sale by an insider is generally not a positive signal, the pre-planned nature suggests it does not reflect a change in the company's fundamental outlook. Therefore, the filing itself does not provide a strong basis for a change in investment recommendation, warranting a 'hold' position based solely on this information.

Keywords

Delek US Holdings, DK, Insider Sale, Form 4, Shlomo Zohar, 10b5-1 Plan, Director Transaction, Equity Sale